Argand Partners has promoted Ryan Beres to senior associate. Prior to joining the middle-market buyout firm, Beres was an investment banking analyst at Goldman Sachs.
Houlihan Lokey has named Sean Fitzgerald as a managing director in the capital markets group. Previously, he worked at Macquarie Capital, where he was a managing director and co-head of U.S. private capital markets.
PlainID, a provider of an advanced authorization platform, has named Richard Bauer as global vice president of sales. PlainID's backers include Viola Ventures.
Austin-based Santé Ventures, a healthcare and life sciences investment firm, has appointed Eric Epstein as senior associate. Previously, he worked at McKinsey & Company where he was an engagement manager.
TZP Group has expanded its team with several new hires and promotions. Joining the private equity firm are Shamit Mehta as partner for growth equity; JoAnne Kruse as portfolio operations partner for talent; Michael Khutorsky as principal; Jarrad Berman as portfolio operations vice president for digital; and Marco Luy as associate. Among the TZP staffers who were recently promoted were Sheera Michael who's now a partner; Harrison Davis, who's now a principal and Matt Doherty, Manvir Heir and Ryan McCarthy, who are all senior associates.
UK-based Artios Pharma Limited, a DNA damage response company developing treatments for cancer, has named Tania Dimitrova as chief business officer. Previously, she worked at Pfizer Inc where she was a director in worldwide business development. Artios is backed by Arix Bioscience plc, SV Health Investors, M Ventures, IP Group plc, AbbVie Ventures, Andera Partners, LSP, Pfizer Ventures and Novartis Venture Fund.
Evercore has named Len Rosen as a senior managing director and CEO of the firm's new business in Israel. Previously, Rosen was the CEO of Barclays Israel. He will be based in Tel Aviv.
San Francisco-based venture firm 500 Startups has named Tony Wang as a managing partner. Prior to joining 500 Startups, Wang was chief operating officer at Color.
EnCap Investments hired a team of four executives to pursue investments in the global transition to lower carbon energy system, including in solar, wind and natural gas. EnCap hired Jim Hughes, Tim Rebhorn, Shawn Cumberland and Kellie Metcalf on the Energy Transition team.
Cannabis-focused investment firm 4Front Ventures Corp has appointed Kathi Lentzsch and Betty Aldworth to its board of directors. Lentzch is the CEO and president of Bartell Drugs while Aldworth is the executive director for Students for Sensible Drug Policy.